Catalyst Wire Dossier Catalyst Wire Dossier

Oral anti-Xa inhibitors

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral anti-Xa inhibitors, covering 2026-03-20 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia [Phase 4]

See pricing